Related Experiment Videos
The use of pentoxifylline in the treatment of systemic sclerosis and lipodermatosclerosis: a unifying hypothesis?
Journal of the American Academy of Dermatology
|July 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Intravascular lasers in the treatment of varicose veins.
Journal of cosmetic dermatology·2006
Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser.
Journal of the American Academy of Dermatology·2001
Laser resurfacing with a long pulse erbium:YAG laser compared to the 950 ms pulsed CO(2) laser.
Lasers in surgery and medicine·2001
Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis.
Journal of the American Academy of Dermatology·2026
Janus Kinase Inhibitor Use in Adults Aged 65 Years and Older: A Clinical Review Across Atopic Dermatitis, Alopecia Areata, and Psoriasis.
Journal of the American Academy of Dermatology·2026
Real-World Systemic Treatment Outcomes for Moderate-to-Severe Atopic Dermatitis in Children by Skin Color: 4-Year Results from the observational, international, real-world PEDISTAD Registry.
Journal of the American Academy of Dermatology·2026
Antibiotic Prophylaxis for Dermatologic Surgery. Part 1: Indications, Guidelines, and Special Populations.
Journal of the American Academy of Dermatology·2026
Dermatological Manifestations of Emergent Viruses. Part II: Vector-Borne and Opportunistic Viral Infections.
Journal of the American Academy of Dermatology·2026
Addictive Potential of Methylphenidate: A Systematic Review of Human and Preclinical Behavioral, Clinical and Neurobiological Evidence.
Pharmaceuticals (Basel, Switzerland)·2026
Comparative Neuropharmacological Effects of Antiseizure Drugs on Cultured Myenteric and Dorsal Root Ganglion Neurons.
Pharmaceuticals (Basel, Switzerland)·2026
Computational Prediction of the Severity of Adverse Drug Reactions Caused by Drug-Drug Interactions.
Pharmaceuticals (Basel, Switzerland)·2026